Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia

被引：0
|
作者：
Xuejie Jiang
Ling Jiang
Jiaying Cheng
Fang Chen
Jinle Ni
Changxin Yin
Qiang Wang
Zhixiang Wang
Dan Fang
Zhengshan Yi
Guopan Yu
Qingxiu Zhong
Bing Z. Carter
Fanyi Meng
机构：
[1] Nanfang Hospital,Department of Hematology
[2] Southern Medical University,Department of Hematology
[3] Kanghua Hospital,Section of Molecular Hematology and Therapy, Department of Leukemia
[4] The University of Texas MD Anderson Cancer Center,undefined
来源：
Journal of Translational Medicine | / 19卷
关键词：
EZH2; Chidamide; Leukemia; Chemosensitivity; Smo/Gli-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia
    Jiang, Xuejie
    Jiang, Ling
    Cheng, Jiaying
    Chen, Fang
    Ni, Jinle
    Yin, Changxin
    Wang, Qiang
    Wang, Zhixiang
    Fang, Dan
    Yi, Zhengshan
    Yu, Guopan
    Zhong, Qingxiu
    Carter, Bing Z.
    Meng, Fanyi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [2] Inhibition of EZH1 and EZH2 Restores Chemosensitivity of Leukemia Stem Cells in Acute Myeloid Leukemia By Recruitment of Quiescent AML Stem/Progenitor Cells
    Chang, Kyung Hee
    Alaniz, Zoe
    Nishida, Yuki
    Dos Santos, Cedric E.
    Slosberg, Eric
    Daver, Naval
    Andreeff, Michael
    BLOOD, 2020, 136
  • [3] EZH2 inhibition induces blast differentiation in acute myeloid leukemia
    Lin, Claire
    Chang, Wen-I
    Honeyman, Joshua N.
    Zhou, Lanlan
    Prabhu, Varun V.
    Allen, Joshua
    El-Deiry, Wafik
    CANCER RESEARCH, 2022, 82 (12)
  • [4] NOVEL LEUKEMIA STEM CELL-TARGETED THERAPY FOR ACUTE MYELOID LEUKEMIA BASED ON DUAL INHIBITION OF EZH1/EZH2
    Kitabayashi, I.
    Fujita, S.
    Takamatsu, E.
    Honma, D.
    Adachi, N.
    Atsushi, I.
    Araki, K.
    HAEMATOLOGICA, 2016, 101 : 222 - 222
  • [5] Novel leukemia stem cell-targeted therapy for acute myeloid leukemia based on dual inhibition of EZH1/EZH2
    Fujita, Shuhei
    Honma, Daisuke
    Araki, Kazushi
    Aoyama, Kazumasa
    Iwama, Atsushi
    Kitabayashi, Issay
    CANCER RESEARCH, 2016, 76
  • [6] EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway
    Zhang, Hao
    Gu, Huizi
    Li, Limei
    Ren, Yuan
    Zhang, Lijun
    TUMOR BIOLOGY, 2016, 37 (05) : 5919 - 5923
  • [7] POLYCYSTIN-1 REGULATES EZH2 EXPRESSION THROUGH THE CAMP/PKA PATHWAY AND EZH2 INHIBITION DELAYS ADPKD PROGRESSION
    Wu, Ming
    Mei, Changlin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [8] Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through PIK3IP1-PI3K/AKT Axis in Acute Myeloid Leukemia
    Yang, Chan
    Zi, Jie
    Song, Chunhua
    Ge, Zheng
    BLOOD, 2021, 138
  • [9] Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin
    Han, Yixiang
    Ye, Aifang
    Zhang, Yan
    Cai, Zhimin
    Wang, Wei
    Sun, Lan
    Jiang, Songfu
    Wu, Jianbo
    Yu, Kang
    Zhang, Shenghui
    PLOS ONE, 2015, 10 (08):
  • [10] Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia
    Yang, Xiaoyang
    Wan, Mengjie
    Yu, Feng
    Wu, Xiuji
    CELLULAR SIGNALLING, 2021, 87
12345